...North America Equity Research 06 January 2014 2014 Global Biotech Outlook Differentiated Growth, Advancing Pipelines Should Drive Outperformance; Conf Call at 11am ET Today The biotech sector had a stellar 2013 (NBI: +65%; S&P: +29%) driven by strong demand for the sector’s key products, many positive phase 3 studies and a wave of successful IPOs. Looking to 2014, we think the fundamental backdrop is very similar with 1) beatable revenue growth expectations (2014e: +16% vs. 2012/2013: +12%) including several high-profile drug launches, 2) many pivotal studies set to read out and 3) a stable/favorable regulatory and reimbursement environment. Notably, these factors should continue to make biotech attractive to generalist investors, who played a major role in the 2013 outperformance. Our bias is to stick with large caps as well as mid-caps with approved products; revenue/EPS/cash flow forecasts for 2015 and beyond look broadly beatable, in our view. In contrast, we suspect that “pure pipeline” or tech platform small caps could be more volatile in 2014. We continue to believe that the biotech industry is in the early innings of an innovation cycle with many labelexpansion opportunities and novel agents in phase 2 or 3 trials that are largely unaccounted for in Street models. Hence, we are bullish on the group for 2014. Please join us for a call today at 11am ET to discuss our sector outlook/favorite names (US dial-in: 888-889-1309; OUS: 773-756-0161; Passcode: BIOTECH). Large-cap...
Words: 13041 - Pages: 53
...many of those concerns. Behind an EPS loss of 13c vs. consensus +30c were several soft spots – Tesla missed 4Q deliveries and guided softly for 1Q’15, ZEV credits artificially boosted results, opex grew faster than expected, and capex was guided well ahead of our conservative model. The result reinforces that Tesla’s push to become a mass market OEM is much harder than it looks. We reiterate our EW rating and remain cautious on the stock near-term. Unchanged USD 190.00 Price Target lowered -5% from USD 200.00 Price (11-Feb-2015) USD 212.80 Potential Upside/Downside -11% Tickers TSLA 26681 Shares Outstanding (mn) Don’t get caught up with ambitious mid/long-term targets…: Despite the weak quarter, there was enough to keep the die-hard bulls interested. Our take - don’t get caught up in it. On the demand side, Musk noted Tesla could reach its ‘15 S/X delivery guide of 55k even ex. China, and has a “secret weapon” which could be deployed later this year. Model S gross margin was guided to 30% for 4Q, and management is confident it should be able to grow X gross margin to a similar level. Longer term, Musk cited confidence in generating significant cash flow and attaining op. margin of 1015%. For the real long-term fanatics, Musk’s comment about seeing a path to reaching Apple’s current market cap of $700bn implies sales of nearly...
Words: 12089 - Pages: 49
...CHATTOPADHYAY, DEBJIT, ET AL 9 - 21 Rpt. 25736145 01-Apr-2015 SAREPTA THERAPEUTICS INC CANACCORD GENUITY - RESEARCH DEPARTMENT 22 - 28 Rpt. 25736256 01-Apr-2015 SAREPTA THERAPEUTICS INC PIPER JAFFRAY - COMPANY REPORT - TENTHOFF, EDWARD, ET AL 29 - 32 Rpt. 25733910 01-Apr-2015 SAREPTA THERAPEUTICS INC COWEN AND COMPANY - BARAL, RITU, ET AL 33 - 37 Rpt. 25736405 01-Apr-2015 SAREPTA THERAPEUTICS INC CREDIT SUISSE - NORTH AMERICA - SHEPARD, JEREMIAH, ET AL 38 - 56 Rpt. 25732665 01-Apr-2015 SAREPTA THERAPEUTICS INC RBC CAPITAL MARKETS (CANADA) - SIMEONIDIS, SIMOS, ET AL 57 - 62 Rpt. 25732827 01-Apr-2015 SAREPTA THERAPEUTICS INC JMP SECURITIES LLC - COMPANY REPORTS - BAYKO, LIISA 63 - 67 Rpt. 25735100 01-Apr-2015 SAREPTA THERAPEUTICS INC OPPENHEIMER AND CO - RESEARCH DEPARTMENT 68 - 72 Rpt. 25736008 01-Apr-2015 SAREPTA THERAPEUTICS INC RBC CAPITAL MARKETS (CANADA) - SIMEONIDIS, SIMOS, ET AL 73 - 78 These reports were compiled using a product of Thomson Reuters www.thomsonreuters.com 1 Table of Contents Rpt. 25736195 01-Apr-2015 SAREPTA THERAPEUTICS INC WILLIAM BLAIR & COMPANY - LUGO, TIM, ET AL 79 - 83 Rpt. 25736196 01-Apr-2015 SAREPTA THERAPEUTICS INC LEERINK PARTNERS LLC - SCHWARTZ, JOSEPH, ET AL 84 - 87 Rpt. 25684726 24-Mar-2015 SAREPTA THERAPEUTICS INC COWEN AND COMPANY - BARAL, RITU, ET AL 88 - 97 Rpt. 25676066 23-Mar-2015 SAREPTA THERAPEUTICS INC JMP SECURITIES...
Words: 46710 - Pages: 187
...an industry where fixed costs make scale paramount; the only "two-legged" balanced player, leading with mega-brands in both Leather Goods and Wines & Spirits; enjoying stable group EBIT margins as a consequence Champagne consumer demand weakness, de-stocking and oversupply in 2010 are well understood; W&S concerns have depressed the stock close to 20-year trough multiples and in the same range of smaller and more volatile hard luxury players and other peers; an opportunity in our view On top of LVMH's unrivaled industry position, markets seem to under-appreciate cost-saving opportunities, brand-portfolio rationalization, higher FCF from lower W&S inventory investment, above-average mega-brands' results or support from first-mover EM inroads In a medium-term growth environment, LVMH has the chance to be a key consolidator in the luxury goods industry: a mega-merger with CFR would be a strategic master stroke, placing it ahead of any M&A counter move by competitors SEE DISCLOSURE APPENDIX OF THIS REPORT FOR IMPORTANT DISCLOSURES AND ANALYST CERTIFICATIONS LVMH: KING OF THE LUXURY JUNGLE 1 Portfolio Manager's Summary We have few doubts about the opportunity of investing in LVMH for the medium to long term. We expect "winners will continue to win" in the luxury industry. LVMH with its material scale advantage, leading brand portfolio, balanced category and geographic exposure is set to dominate over competitors in the long term. LVMH's mega-brands and...
Words: 54550 - Pages: 219
...Regional Morning Pack DBS Group Research . Equity 01 October 2009 Spotlight On (SP) Hiap Seng: Undervalued oil and gas play (Initiate Coverage) BUY; S$0.69; HSE SP; Price Target: 12-Month S$0.90 • • • • Huge 40-60% discount to peers is unwarranted. Expect high dividends of 4.0-4.5 Scents per share. Margins improvement to support earnings growth. Initiate coverage with a BUY rating. 30% upside to our target price of S$0.90. Ideas & Updates REGIONAL US Fed: Two collision courses SINGAPORE Banking: Positive uptick in loans Hiap Seng (Initiate Coverage) – See Spotlight MALAYSIA Tanjong PLC: Attractive yield play BUY; RM15.00; TJN MK; Price Target: 12-month RM19.25 HONG KONG PUBLIC HOLIDAY THAILAND Charoen Pokphand Foods – See Spotlight (TB) Charoen Pokphand Foods: Earnings surge, costs remain low BUY; Bt7.95; CPF TB; Price Target: 12-Month Bt9.60 (Prev Bt7.50) • • • 3Q09F will beat record high 2Q09 earnings Promising outlook with firm product prices, low raw material costs, and improving margins Raised earnings, and TP to Bt9.60. Undemanding valuation, 21% upside, maintain BUY. Singapore Research Team – 6533 9688 research@dbsvickers.com www.dbsvickers.com “In Singapore, this research report or research analyses may only be distributed to Institutional Investors, Expert Investors or Accredited Investors as defined in the Securities and Futures Act, Chapter 289 of Singapore.” “Recipients of this report, received from DBS Vickers Research (Singapore) Pte Ltd (“DBSVR”)...
Words: 21991 - Pages: 88
...Secular Stagnation: Facts, Causes and Cures Edited by Coen Teulings and Richard Baldwin CEPR Press a A VoxEU.org Book Secular Stagnation: Facts, Causes, and Cures A VoxEU.org eBook Centre for Economic Policy Research (CEPR) Centre for Economic Policy Research 3rd Floor 77 Bastwick Street London, EC1V 3PZ UK Tel: +44 (0)20 7183 8801 Email: cepr@cepr.org Web: www.cepr.org ISBN: 978-1-907142-77-2 © CEPR Press, 2014 Secular Stagnation: Facts, Causes, and Cures A VoxEU.org eBook edited by Coen Teulings and Richard Baldwin CEPR Press abcde Centre for Economic Policy Research (CEPR) The Centre for Economic Policy Research (CEPR) is a network of almost 900 research economists based mostly in European universities. The Centre’s goal is twofold: to promote world-class research, and to get the policy-relevant results into the hands of key decision-makers. CEPR’s guiding principle is ‘Research excellence with policy relevance’. A registered charity since it was founded in 1983, CEPR is independent of all public and private interest groups. It takes no institutional stand on economic policy matters and its core funding comes from its Institutional Members and sales of publications. Because it draws on such a large network of researchers, its output reflects a broad spectrum of individual viewpoints as well as perspectives drawn from civil society. CEPR research may include views on policy, but the Executive Committee of the Centre does not give prior...
Words: 47021 - Pages: 189
...calmer waters.1 While a full recovery for chemical companies is not expected this year, certainly, the earnings releases across the industry for the first half of 2010 suggest that growth is returning at a faster rate than many had expected.2 Increased production in the domestic auto industry is supporting new demand for US chemical products, but the construction sector – another major market for US chemicals – is recovering more slowly. However, after massive layoffs, improvements in cash management and operational belttightening, the US chemical industry is expected to realize a year-over-year increase of around 7 percent in 2010, according to the American Chemistry Council (ACC).3 At the same time, this recovery presents its own set of challenges for US chemical companies. The growing size and diversity of emerging markets, the increasing influence of chemical producers in the Middle East, Asia and Latin America, the increased burden of environmental regulations and many other factors have created a new global playing field in which US companies are no longer taking their technical, financial and market advantages for granted....
Words: 8500 - Pages: 34
...PV StatuS RePoRt EUR 24807 EN - 2011 The Institute for Energy provides scientific and technical support for the conception, development, implementation and monitoring of community policies related to energy. Special emphasis is given to the security of energy supply and to sustainable and safe energy production. European Commission Joint Research Centre Institute for Energy Contact information Address: Via Enrico Fermi 2749 TP 450 21027 Ispra (VA) Italy E-mail: arnulf.jaeger-waldau@ec.europa.eu Tel.: +39 0332 789119 Fax: +39 0332 789268 http://ie.jrc.ec.europa.eu www.jrc.ec.europa.eu PV Status Report 2011 Research, Solar Cell Production and Market Implementation of Photovoltaics July 2011 Arnulf Jäger-Waldau European Commission, DG Joint Research Centre, Institute for Energy, Renewable Energy Unit Via Enrico Fermi 2749; TP 450 I – 21027 Ispra (VA), Italia EUR 24807 EN Legal notice Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use, which might be made of the following information. The report does not represent any official position of the European Commission, nor do its contents prejudge any future Commission proposals in any areas of Community policy. A great deal of additional information on the European Union is available on the Internet. It can be accessed through the Europa server http://europa.eu/ JRC 64900 EUR 24807 EN ISBN 978-92-79-20171-4 ISSN 1831-4155 doi 10.2788/87966 The report...
Words: 62002 - Pages: 249
...Invest. Innovate. Inspire. For a new India. ANNUAL REPORT 2014-15 India is at the threshold of a new era of growth and opportunity. This is driven by increasing economic activity, ongoing ‘Make in India’ initiatives and a demographically well-placed, aspirational society. Reliance Industries Limited (RIL) continues to be a partner in India’s ongoing journey towards economic and social well-being, and remains committed to investing in and innovating for India. RIL is striving to meet and exceed global benchmarks in product quality and customer service with inspiring ideas and strategic investments. From the manufacturing landscape to high-growth consumer service sectors, RIL is achieving superior outcomes that facilitate India’s drive for global leadership. RIL is delivering industry-leading performance through consistent efficiency in operations and prudent configuration of assets. RIL is making sizable capital investments, focusing on technology and expanding its level of services from the hydrocarbons sector to consumer businesses. RIL innovates for existing businesses and also focuses on developing new business models to deliver g g g y significant value for its growing stakeholder fraternity. In this effort, it collaborates with o s with leading global institutions to help usher in a n era of possibilities. global new is growing o RIL’s focus is to continue growing as a respons responsible organisation, thereby e inspiring progress in...
Words: 182744 - Pages: 731
.... UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF NEW YORK ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ x : In re : : LEHMAN BROTHERS HOLDINGS INC., : et al., : : Debtors. : ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ x Chapter 11 Case No. 08‐13555 (JMP) (Jointly Administered) REPORT OF ANTON R. VALUKAS, EXAMINER March 11, 2010 Jenner & Block LLP 353 N. Clark Street Chicago, IL 60654‐3456 312‐222‐9350 919 Third Avenue 37th Floor New York, NY 10022‐3908 212‐891‐1600 Counsel to the Examiner VOLUME 1 OF 9 Sections I & II: Introduction, Executive Summary & Procedural Background Section III.A.1: Risk EXAMINER’S REPORT TABLE OF CONTENTS VOLUME 1 Introduction, Sections I & II: Executive Summary & Procedural Background Introduction ...................................................................................................................................2 I. Executive Summary of The Examiner’s Conclusions ......................................................15 A. Why Did Lehman Fail? Are There Colorable Causes of Action That Arise From Its Financial Condition and Failure?..................................................................15 B. Are There Administrative Claims or Colorable Claims For Preferences or Voidable Transfers...
Words: 71002 - Pages: 285
...CONTENTS: CASE STUDIES CASE STUDY 1 Midsouth Chamber of Commerce (A): The Role of the Operating Manager in Information Systems CASE STUDY I-1 IMT Custom Machine Company, Inc.: Selection of an Information Technology Platform CASE STUDY I-2 VoIP2.biz, Inc.: Deciding on the Next Steps for a VoIP Supplier CASE STUDY I-3 The VoIP Adoption at Butler University CASE STUDY I-4 Supporting Mobile Health Clinics: The Children’s Health Fund of New York City CASE STUDY I-5 Data Governance at InsuraCorp CASE STUDY I-6 H.H. Gregg’s Appliances, Inc.: Deciding on a New Information Technology Platform CASE STUDY I-7 Midsouth Chamber of Commerce (B): Cleaning Up an Information Systems Debacle CASE STUDY II-1 Vendor-Managed Inventory at NIBCO CASE STUDY II-2 Real-Time Business Intelligence at Continental Airlines CASE STUDY II-3 Norfolk Southern Railway: The Business Intelligence Journey CASE STUDY II-4 Mining Data to Increase State Tax Revenues in California CASE STUDY II-5 The Cliptomania™ Web Store: An E-Tailing Start-up Survival Story CASE STUDY II-6 Rock Island Chocolate Company, Inc.: Building a Social Networking Strategy CASE STUDY III-1 Managing a Systems Development Project at Consumer and Industrial Products, Inc. CASE STUDY III-2 A Make-or-Buy Decision at Baxter Manufacturing Company CASE STUDY III-3 ERP Purchase Decision at Benton Manufacturing Company, Inc. CASE STUDY III-4 ...
Words: 239887 - Pages: 960
